US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist

13.970
-1.150-7.61%

Close Nov 15 16:00 ET

14.050
+0.080+0.57%

Post 19:45 ET

1.42BMarket Cap-2563P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-24.02%9.11M

-48.82%6.96M

129.53%28.94M

-30.40%36.28M

-114.12%-1.92M

-9.60%11.99M

-3.11%13.59M

12.03%12.61M

57.69%52.12M

5.59%13.57M

Operating revenue

-24.02%9.11M

-48.82%6.96M

129.53%28.94M

-30.40%36.28M

-114.12%-1.92M

-9.60%11.99M

-3.11%13.59M

12.03%12.61M

57.69%52.12M

5.59%13.57M

Cost of revenue

Gross profit

Operating expense

7.53%153.88M

0.05%146M

14.75%142.94M

8.09%551.57M

11.58%137.98M

20.46%143.1M

29.91%145.93M

-19.89%124.56M

69.58%510.29M

32.58%123.66M

Selling and administrative expenses

3.73%30.5M

3.72%31.79M

13.27%31.09M

29.00%116.5M

22.72%28.99M

32.77%29.4M

38.50%30.65M

22.52%27.45M

27.02%90.31M

6.87%23.63M

-General and administrative expense

3.73%30.5M

3.72%31.79M

13.27%31.09M

29.00%116.5M

22.72%28.99M

32.77%29.4M

38.50%30.65M

22.52%27.45M

27.02%90.31M

6.87%23.63M

Research and development costs

8.52%123.38M

-0.93%114.21M

15.17%111.85M

3.59%435.07M

8.94%108.98M

17.64%113.7M

27.80%115.28M

-27.03%97.12M

82.75%419.98M

40.57%100.03M

Operating profit

-10.42%-144.77M

-5.07%-139.04M

-1.83%-114M

-12.47%-515.29M

-27.07%-139.89M

-24.24%-131.11M

-34.62%-132.33M

22.38%-111.96M

-71.05%-458.16M

-36.90%-110.09M

Net non-operating interest income expense

-4.85%12.12M

-1.83%12.42M

5.44%12.63M

483.38%49.83M

132.70%12.46M

555.01%12.74M

1,699.86%12.65M

2,118.52%11.98M

565.78%8.54M

964.41%5.35M

Non-operating interest income

-4.85%12.12M

-1.83%12.42M

5.44%12.63M

483.38%49.83M

132.70%12.46M

555.01%12.74M

1,699.86%12.65M

2,118.52%11.98M

565.78%8.54M

964.41%5.35M

Other net income (expense)

20.56%-3.06M

-408.85%-20.35M

-92.66%-6.07M

35.95%-15.73M

45.49%-4.73M

60.01%-3.86M

-29.87%-4M

0.57%-3.15M

-1,753.89%-24.56M

-8.67M

Gain on sale of security

---3.06M

---20.35M

---6.07M

----

Earnings from equity interest

--0

-41.10%-15.63M

-45.57%-4.73M

-110.31%-3.86M

-23.00%-4M

-11.04%-3.05M

-736.15%-11.08M

-145.13%-3.25M

Special income (charges)

--0

99.26%-100K

--0

76.25%-100K

---13.49M

---5.43M

-Less：Restructuring and merger&acquisition

--0

-99.26%100K

--0

-76.25%100K

--13.49M

--5.43M

Income before tax

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

-77.01%-474.19M

-39.60%-113.41M

Income tax

Net income

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

-77.01%-474.19M

-39.60%-113.41M

Net income continuous Operations

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

-77.01%-474.19M

-39.60%-113.41M

Minority interest income

Net income attributable to the parent company

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

-77.01%-474.19M

-39.60%-113.41M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-11.04%-135.71M

-18.83%-146.98M

-4.18%-107.44M

-1.48%-481.19M

-16.54%-132.16M

-7.94%-122.22M

-22.85%-123.68M

29.79%-103.13M

-77.01%-474.19M

-39.60%-113.41M

Basic earnings per share

2.90%-1.34

-8.57%-1.52

4.27%-1.12

12.01%-5.42

-4.29%-1.46

7.38%-1.38

-5.26%-1.4

40.31%-1.17

-62.96%-6.16

-28.44%-1.4

Diluted earnings per share

2.90%-1.34

-8.57%-1.52

4.27%-1.12

12.01%-5.42

-4.29%-1.46

7.38%-1.38

-5.26%-1.4

40.31%-1.17

-62.96%-6.16

-28.44%-1.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-24.02%9.11M	-48.82%6.96M	129.53%28.94M	-30.40%36.28M	-114.12%-1.92M	-9.60%11.99M	-3.11%13.59M	12.03%12.61M	57.69%52.12M	5.59%13.57M
Operating revenue	-24.02%9.11M	-48.82%6.96M	129.53%28.94M	-30.40%36.28M	-114.12%-1.92M	-9.60%11.99M	-3.11%13.59M	12.03%12.61M	57.69%52.12M	5.59%13.57M
Cost of revenue
Gross profit
Operating expense	7.53%153.88M	0.05%146M	14.75%142.94M	8.09%551.57M	11.58%137.98M	20.46%143.1M	29.91%145.93M	-19.89%124.56M	69.58%510.29M	32.58%123.66M
Selling and administrative expenses	3.73%30.5M	3.72%31.79M	13.27%31.09M	29.00%116.5M	22.72%28.99M	32.77%29.4M	38.50%30.65M	22.52%27.45M	27.02%90.31M	6.87%23.63M
-General and administrative expense	3.73%30.5M	3.72%31.79M	13.27%31.09M	29.00%116.5M	22.72%28.99M	32.77%29.4M	38.50%30.65M	22.52%27.45M	27.02%90.31M	6.87%23.63M
Research and development costs	8.52%123.38M	-0.93%114.21M	15.17%111.85M	3.59%435.07M	8.94%108.98M	17.64%113.7M	27.80%115.28M	-27.03%97.12M	82.75%419.98M	40.57%100.03M
Operating profit	-10.42%-144.77M	-5.07%-139.04M	-1.83%-114M	-12.47%-515.29M	-27.07%-139.89M	-24.24%-131.11M	-34.62%-132.33M	22.38%-111.96M	-71.05%-458.16M	-36.90%-110.09M
Net non-operating interest income expense	-4.85%12.12M	-1.83%12.42M	5.44%12.63M	483.38%49.83M	132.70%12.46M	555.01%12.74M	1,699.86%12.65M	2,118.52%11.98M	565.78%8.54M	964.41%5.35M
Non-operating interest income	-4.85%12.12M	-1.83%12.42M	5.44%12.63M	483.38%49.83M	132.70%12.46M	555.01%12.74M	1,699.86%12.65M	2,118.52%11.98M	565.78%8.54M	964.41%5.35M
Other net income (expense)	20.56%-3.06M	-408.85%-20.35M	-92.66%-6.07M	35.95%-15.73M	45.49%-4.73M	60.01%-3.86M	-29.87%-4M	0.57%-3.15M	-1,753.89%-24.56M	-8.67M
Gain on sale of security	---3.06M	---20.35M	---6.07M	----	----	----	----	----	----	----
Earnings from equity interest	--0	--0	--0	-41.10%-15.63M	-45.57%-4.73M	-110.31%-3.86M	-23.00%-4M	-11.04%-3.05M	-736.15%-11.08M	-145.13%-3.25M
Special income (charges)	--0	--0	--0	99.26%-100K	--0	--0	--0	76.25%-100K	---13.49M	---5.43M
-Less：Restructuring and merger&acquisition	--0	--0	--0	-99.26%100K	--0	--0	--0	-76.25%100K	--13.49M	--5.43M
Income before tax	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M	-77.01%-474.19M	-39.60%-113.41M
Income tax
Net income	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M	-77.01%-474.19M	-39.60%-113.41M
Net income continuous Operations	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M	-77.01%-474.19M	-39.60%-113.41M
Minority interest income
Net income attributable to the parent company	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M	-77.01%-474.19M	-39.60%-113.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-11.04%-135.71M	-18.83%-146.98M	-4.18%-107.44M	-1.48%-481.19M	-16.54%-132.16M	-7.94%-122.22M	-22.85%-123.68M	29.79%-103.13M	-77.01%-474.19M	-39.60%-113.41M
Basic earnings per share	2.90%-1.34	-8.57%-1.52	4.27%-1.12	12.01%-5.42	-4.29%-1.46	7.38%-1.38	-5.26%-1.4	40.31%-1.17	-62.96%-6.16	-28.44%-1.4
Diluted earnings per share	2.90%-1.34	-8.57%-1.52	4.27%-1.12	12.01%-5.42	-4.29%-1.46	7.38%-1.38	-5.26%-1.4	40.31%-1.17	-62.96%-6.16	-28.44%-1.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data